Trials / Completed
CompletedNCT00354965
Pharmacokinetic Profiles Of Amoxicillin 2000 mg And Clavulanate 125 mg In Adolescent Patients
A Study to Determine PK Profiles of AUGMENTIN XR in Adolescents Weight at Least 40 kg Receiving Augmentin XR BID for 10 Days
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
Clinical research study to test amoxicillin and clavulanate tablet formulation for use in Acute Bacterial Sinusitis (ABS) in adolescent patients weighing at least 40 kilogram (kg) and no more than 16 years old. ABS is an acute bacterial infection of the sinus. The purpose of this study is to find out how children tolerate Augmentin XR and what happens to Augmentin XR in the body after it has been swallowed by children.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | amoxicillin/clavulanate potassium | amoxicillin/clavulanate potassium |
Timeline
- Start date
- 2006-01-19
- Primary completion
- 2007-04-02
- Completion
- 2007-04-02
- First posted
- 2006-07-20
- Last updated
- 2017-08-01
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00354965. Inclusion in this directory is not an endorsement.